Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
|
|
Ovid Therapeutics Inc. (OVID)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.5, valued at
$437.5k
|
|
| 02/27/2023 |
4
| Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.5, valued at
$437.5k
|
|
| 02/27/2023 |
4
| Poole Robert Michael (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 02/27/2023 |
4
| Perone Thomas Michael (General Counsel, Secretary) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 175,000 options to buy
@ $2.5, valued at
$437.5k
|
|
| 02/27/2023 |
4
| LEVIN JEREMY M (CEO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 600,000 options to buy
@ $2.5, valued at
$1.5M
|
|
| 02/27/2023 |
4
| Friedman Bart (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 02/27/2023 |
4
| Fitzgerald Kevin Joseph (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 02/27/2023 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 02/27/2023 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.5, valued at
$37.5k
|
|
| 09/14/2022 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Sold 17,344 shares
@ $2.15, valued at
$37.3k
|
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| Friedman Bart (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 69,424 options to buy
@ $3.22, valued at
$223.5k
|
|
| 04/12/2022 |
4
| Tardio Jason (COO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 87,498 options to buy
@ $3.22, valued at
$281.7k
Granted 10,000 options to buy
@ $3.22, valued at
$32.2k
|
|
| 04/12/2022 |
4
| LEVIN JEREMY M (CEO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 423,244 options to buy
@ $3.22, valued at
$1.4M
|
|
| 04/12/2022 |
4
| Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 194,399 options to buy
@ $3.22, valued at
$626k
Granted 10,000 options to buy
@ $3.22, valued at
$32.2k
|
|
| 04/12/2022 |
4
| Perone Thomas Michael (General Counsel, Secretary) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 25,399 options to buy
@ $3.22, valued at
$81.8k
Granted 10,000 options to buy
@ $3.22, valued at
$32.2k
|
|
| 04/12/2022 |
4
| Duncan Barbara Gayle (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 21,347 options to buy
@ $3.22, valued at
$68.7k
|
|
| 04/12/2022 |
4
| Bernstein Karen (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 69,424 options to buy
@ $3.22, valued at
$223.5k
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Rona Jeffrey A (CBFO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 218,750 options to buy
@ $2.72, valued at
$595k
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
4
| Fitzgerald Kevin Joseph (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.44, valued at
$103.2k
|
|
| 07/16/2021 |
4
| Rakhit Amit (President and CMO) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Sold 34,017 shares
@ $3.71, valued at
$126.2k
Exercised 34,017 options to buy
@ $1.89, valued at
$64.3k
|
|
| 07/13/2021 |
4
| Poole Robert Michael (Director) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 30,000 options to buy
@ $3.94, valued at
$118.2k
|
|
| 07/01/2021 |
4
| Tardio Jason (Chief Commercial Officer) has filed a Form 4 on Ovid Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.95, valued at
$197.5k
|
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|